fbpx

French opticians under pressure

 

If it passes, the French government’s draft law on consumer issues may have strong repercussions in the optical industry.

 

The French government has been upfront: the stated objective of the draft law, which is currently in its second reading in the National Assembly, is to get French people to save by expanding the distribution of lenses and contact lenses, namely to e-commerce. According to Benoît Hamon, Minister for the Economy and Finance, Internet sales of optical products would represent “about a billion euros in purchasing power” for the French people. The minister expects prices to drop by 30 to 40 percent.

 

An amendment to the draft law asks that the initial dispensing of corrective lenses and contact lenses be subject to a medical prescription. Another amendment requires that the pupillary distance be indicated on the prescription in order to encourage the development of the online sale of eyewear. Furthermore, consumers would be able to purchase contact lens care products in supermarkets—not just in pharmacies.

 

The French government justifies this new draft law by saying that, in all of Europe, the French people spend the most on eyewear and contact lenses—$118 (81 euros) a year. Nearly three million French people do not purchase glasses because they are too expensive.

 

Sources:

http://www.acuite.fr/articles.asp?REF=9195

http://www.leparisien.fr/laparisienne/sante/vente-par-internet-de-produits-d-optique-un-gain-d-un-milliard-d-euros-selon-hamon-09-12-2013-3392357.php

 

 

Raising awareness of gifts that are dangerous to eyes

 

Eyecare professionals should take the opportunity in December to remind their patients that certain toys can represent a danger to their children’s eyes.  

 

In the US, Prevent Blindness America takes the issue very seriously and designates December “Safe Toys and Gifts Month.” The not-for-profit organization offers tips on the best ways to choose a safe toy according to the child’s age and on recognizing dangerous toys on one of its website pages: www.preventblindness.org/make-safe-toys-and-gifts-priority. In addition to tips, it includes data on eye injuries caused by toys.

 

It’s important to note that in the US in 2011 there were 262,300 recorded injuries caused by toys, with the head and face being the body parts most often affected. In Canada, the Canadian Association of Optometrists (CAO) issues regular reminders that thousands of children visit emergency rooms each year over the holiday season due to eye injuries caused by toys.

 

To lessen risks, Health Canada suggests in particular avoiding toys that have sharp points and edges and those with arrows, bullets and missiles, and discarding or repairing old or broken toys. Finally, children who have handled sticky gel or soft plastic toys should wash their hands immediately afterward to prevent chemical residues from irritating their eyes.

Sources:

http://www.preventblindness.org/make-safe-toys-and-gifts-priority

http://www.cnib.ca/en/your-eyes/safety/at-play/Pages/child-eyeinjuries-1207.aspx

Eye strain: a sign of our times

 

The 2013 edition of the VisionWatch Survey, carried out for The Vision Council, confirms the role that electronic devices play in eye strain.

 

Among the 7,160 respondents, only 1% does not use any digital devices on a daily basis. Television has the highest daily usage (81.1%), but is most popular among people aged 55 and older. Smart phones (61.7%), laptops (60.9%) and desktops (58.1%) are the next most prominent devices. These devices are particularly popular among the 18 to 34 age group. However, the gap is smaller for the 55 and older age group, indicating that smart phones are becoming more widely adopted by older adults. Finally, 37% of respondents regularly used tablets, while 17.4% used video game consoles.

 

All these devices take a toll on our eyes. Taken together, we use them over many hours every day. A third of respondents use them from 3 to 5 hours a day and a similar proportion use them between 6 and 9 hours a day. Along with neck and shoulder pain, eye strain is the most common symptom reported by users. Over 73% of participants described the symptoms as annoying or irritating, but one out of twenty described the discomfort as painful or excruciating.

 

Almost 40% of the study participants having experienced discomfort have tried to reduce their symptoms; however, many did not know what to do, particularly younger respondents. It is clear that eyecare professionals have become an important source of information and advice on how to decrease irritation.

Source:

www.visionexpoeast.com/Press/Vision-Voice-Newsletter/Research-Article-November-2013/

 

 

 

Anisometropia is frequent in older adults

 

A study, the results of which were published in Optometry and Vision Science, shows that anisometropia is more prevalent in older adults.

 

The researchers followed 118 patients over 12 years. Their average age was 67 at the start of the study and 79 at the end. During this period, the prevalence of anisometropia, which is a significant difference in vision between the eyes, almost doubled. When the patients approached 80 years of age, 32% had the condition.

 

Most cases were related to differing degrees of farsightedness between the eyes. Others were caused by unequal blurring of the lens of the eye, even though none of the subjects had cataracts as such.

 

Differences could begin to occur at any age, and a few patients actually saw their anisometropia decrease over the course of the study.

 

“Whatever the cause of the increase in anisometropia with aging, the fact that significant anisometropia is at least ten times more common in those over 75 years of age than in children needs to be clearly emphasized to clinicians,” says the study’s authors.

 

“Uncorrected anisometropia is likely to lead to disturbances in binocular vision and stereopsis, which in turn may contribute to falls in the elderly,” says Gunilla Haegerstrom-Portnoy, lead author and professor at the University of California, Berkeley.

Source:

http://www.sciencedaily.com/releases/2013/11/131126155834.htm

The glaucoma pill?

 

Oral contraceptives may be a risk factor for glaucoma, according to a study presented at the recent annual meeting of the American Academy of Ophthalmology.

 

The study was led by the University of California, Duke University, in North Carolina, and Nanchang University, in China. The scientists based their research on the medical records of 3,406 American women aged 40 years or older. They discovered that the women who had taken oral contraceptives for three or more years, regardless of the type, were 2.05 times more likely to develop glaucoma.

 

The study found no direct causal link between the contraceptives and glaucoma, but indicates that long-term use of the products could be a potential risk factor for glaucoma. “This study should be an impetus for future research to prove the cause and effect of oral contraceptives and glaucoma,” said Shan Lin, lead researcher, from the University of California San Francisco. “At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors.”

Source:

http://www.sciencedaily.com/releases/2013/11/131118091418.htm

Featured Posts

Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read More
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read More
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read More
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read More
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more